thiotepa
Generic: thiotepa
Labeler: novadoz pharmaceuticals llcDrug Facts
Product Profile
Brand Name
thiotepa
Generic Name
thiotepa
Labeler
novadoz pharmaceuticals llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
thiotepa 15 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72205-045
Product ID
72205-045_fa8d1c84-357b-433d-8f78-89175c9a8cbc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213049
Listing Expiration
2026-12-31
Marketing Start
2020-02-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72205045
Hyphenated Format
72205-045
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
thiotepa (source: ndc)
Generic Name
thiotepa (source: ndc)
Application Number
ANDA213049 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 15 mg/1
Packaging
- 1 VIAL, GLASS in 1 BOX (72205-045-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRACAVITARY", "INTRAVENOUS", "INTRAVESICAL"], "spl_id": "fa8d1c84-357b-433d-8f78-89175c9a8cbc", "openfda": {"nui": ["N0000000236", "N0000175558"], "unii": ["905Z5W3GKH"], "rxcui": ["1660004", "1660009"], "spl_set_id": ["b702dcc9-dd0e-4386-b1e2-f20562fd2ad9"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 BOX (72205-045-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "72205-045-01", "marketing_start_date": "20200201"}], "brand_name": "Thiotepa", "product_id": "72205-045_fa8d1c84-357b-433d-8f78-89175c9a8cbc", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "72205-045", "generic_name": "Thiotepa", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Thiotepa", "active_ingredients": [{"name": "THIOTEPA", "strength": "15 mg/1"}], "application_number": "ANDA213049", "marketing_category": "ANDA", "marketing_start_date": "20200201", "listing_expiration_date": "20261231"}